Based on the treatment scheme, breast cancer is divided into three types, (1) HER2-positive; (2) hormone receptor-positive (ER+ and/or PR+), (i.e. luminal A and B); and (3) triple-negative (ER-, PR-, HER2-)[2]. Here, PGR is linked to breast carcinoma.